Industry News

Smith & Nephew launches cruciate retaining natural-motion knee implant

Smith & Nephew released its JOURNEY II Cruciate Retaining knee replacement implant at the American Academy of Orthopaedic Surgeons Annual Meeting.

According to a company press release, the PCL-sparing total knee replacement implant is designed to provide normal kinematics and increased patient satisfaction. The implant reproduces the shapes of the joint's hard surfaces and the normal force behavior of the soft tissues. This helps the soft tissue's readjustment after surgery and aids in returning the patient's stride to its natural motion.

“The JOURNEY II CR knee will be a key component of our total knee replacement portfolio,” Gaurav Agarwal, Smith & Nephew’s president of orthopaedic reconstruction, stated in the release. “The unique patient benefits of the JOURNEY II BCS knee have made it among the most popular implants we have ever introduced, and since our customers choose a PCL-sparing device in approximately one-half of knee replacement cases, we expect the new JOURNEY II CR to further drive adoption of the JOURNEY II system.”

Smith & Nephew released its JOURNEY II Cruciate Retaining knee replacement implant at the American Academy of Orthopaedic Surgeons Annual Meeting.

According to a company press release, the PCL-sparing total knee replacement implant is designed to provide normal kinematics and increased patient satisfaction. The implant reproduces the shapes of the joint's hard surfaces and the normal force behavior of the soft tissues. This helps the soft tissue's readjustment after surgery and aids in returning the patient's stride to its natural motion.

“The JOURNEY II CR knee will be a key component of our total knee replacement portfolio,” Gaurav Agarwal, Smith & Nephew’s president of orthopaedic reconstruction, stated in the release. “The unique patient benefits of the JOURNEY II BCS knee have made it among the most popular implants we have ever introduced, and since our customers choose a PCL-sparing device in approximately one-half of knee replacement cases, we expect the new JOURNEY II CR to further drive adoption of the JOURNEY II system.”